“With the exception of safe water, no other modality, not even antibiotics, has had such a major effect on mortality reduction …” Plotkin S, OrensteinW, Offit P; Vaccines, 5th Ed. Saunders, 2008.

Biovac has supplied vaccines for the Expanded Programme on Immunisation (EPI) in South Africa since 2003. For the last 15 years we have played a pivotal role in supporting the South African Department of Health during introductions of new vaccines and during vaccination campaigns.

Currently, we supply over 15 million doses of vaccines annually to the South African provinces.

The following are the vaccines supplied in South Africa and the diseases they prevent:

Disease Vaccine
Tuberculosis Bacille Calmette-Guerin Vaccine – BCG
Measles Measles Vaccine
Pneumonia Pneumococcal Conjugate Vaccine
Hepatitis B Hepatitis B Vaccine
Diphtheria, Tetanus, Pertussis, Poliomyelitis, Haemophilus influenzae b infection and Hepatitis B Hexavalent Vaccine
Tetanus Tetanus Toxoid Vaccine

Beyond South Africa, The Biovac Institute supplies vaccines and other biologicals within the South African Development Community (SADC) region and continues to explore relationships to expand our reach.

Video: GBS Vaccine Development by S&I

Play video from